Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development of therapies for hepatitis delta virus (HDV) and other serious diseases, appointed William Kachioff as chief financial officer and James Vollins general counsel, chief compliance officer and corporate secretary. Kachioff is experienced in corporate finance, investor relations, capital formation, corporate governance and manufacturing accounting and systems. He has more 30 years of life scie...